Credit
Tuesday, Oct. 25, 2022
Advanced genomic assays have been used in the research setting to diagnose undiagnosed disease patients. Strategies that vastly reduce the cost of sequencing will enable broader reach to underinsured and underserved populations. Another impact will be vastly increasing data density and read depth with concomitant improvement in sensitivity and throughput. This symposium brings together leaders in clinical genomic implementation and advanced genome sequencing technologies to present their efforts to translate these methods to the clinical diagnostic laboratory setting.
The symposium will be held at the 2022 Annual Meeting of the American Society of Human Genetics and is sponsored by the Department of Molecular and Human Genetics and the Undiagnosed Diseases Center at Baylor College of Medicine.
Location: Rm. 402AB, Los Angeles Convention Center
Lunch will be served from 11:15 - 11:30 a.m.
Talks begin at 11:45 a.m. and last until 12:45 p.m.
Speakers / Topics:
Introduction
Brendan Lee, M.D., Ph.D.
Robert and Janice McNair Endowed Chair and Professor, Department of Molecular and Human Genetics, Baylor College of Medicine
Deep RNAseq for Undiagnosed Disease Diagnosis
Pengfei Liu, Ph.D.
Assistant Professor, Department of Molecular and Human Genetics, Baylor College of Medicine
Validation for Cinical Reporting of Whole Genome Sequencing
Christine Eng, M.D.
Professor and Vice Chair for Diagnostic Laboratory Affairs, Department of Molecular and Human Genetics, Baylor College of Medicine
Chief Quality Officer, Chief Medical Officer, Baylor Genetics
Novel Sequencing Technologies for WGS-based Clinical Genomics
Doron Lipson, Ph.D.
CSO, Ultima Genomics, Israel
